Loading clinical trials...
Loading clinical trials...
The Digital Cognitive Multi-domain Alzheimer's Risk Velocity (DC MARVEL) study is a 2-year randomized controlled trial on dementia prevention. The purpose of this study is to determine the effect of a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neurotrack Technologies, Inc.
Collaborators
NCT07571161 · Alzheimer Disease
NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
NCT06347315 · Mild Cognitive Impairment
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT06937229 · Alzheimer Disease, Agitation
University of Arkansas
Fayetteville, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions